drugset / Trial / NCT02270281

Dexmedetomidine on Microcirculation in Septic Shock

NCT02270281 ↗

Phase 4 Completed 44 enrolled Southeast University, China
NaSingle-groupOpen-labelTreatment

Summary

Dexmedetomidine was found might be beneficial to sepsis. Dexmedetomidine were found to improve microcirculation in sepsis animal studies and non-sepsis patients. However, the effect of dexmedetomidine on microcirculation in septic shock patients is unknown.

Timeline

Start
2014-12
Primary completion
2016-12
Completion
2017-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.7 ug/kg Intravenous